Since TLR4 is involved in critical steps of plaque formation, and Feraheme is readily taken up by macrophages involved in the resulting inflammatory process, both fluorescent tracers show promise in being able to identify high-risk plaques likely to progress and can be included in the arsenal of molecular probes for NIRF imaging of atherosclerosis [7]. This evidence concerns the gene TLR4 and atherosclerosis.